APHARMAT
ActiveFrom the official registers: KBO 15 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
APHARMAT has been active since 2010 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €49,674 and a net result of €52,995. Equity is growing by about 44% per year across the filed financial years. Its solvency ranks better than 15% of 12,737 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
05-10
Gazette deed
Resignation: Katelijne Valkaert (director)3 facts ▸
Gazette deed
Resignation: Katelijne Valkaert (director)
3 facts ▸
- General meeting, 29-09-2026
- Director resignation, Katelijne Valkaert (director)
- Other provision, “document number”, 26369317 (deed in Dutch)
15-07
financial year 2025 · abbreviated format
2025
14-07
financial year 2024 · abbreviated format
2024
22-07
financial year 2023 · abbreviated format
2023
05-05
financial year 2022 · abbreviated format
2022
20-07
financial year 2021 · abbreviated format
2021
31-12
Financial
Highest result from 2018 to 2025net €84,054 ▲279%
Operating result €130,702, net result €84,054, both a record.
05-08
financial year 2020 · abbreviated format · 5 days late
2020
29-07
financial year 2019 · abbreviated format
2019
27-08
financial year 2018 · abbreviated format · 27 days late
2018
31-07
financial year 2017 · abbreviated format
2017
03-08
financial year 2016 · abbreviated format · 3 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank